TWA
RVMD icon

TCI Wealth Advisors’s Revolution Medicines RVMD Stock Holding History

TCI Wealth Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-346
Closed -$7.5K – 1831
2023
Q1 		$7.5K Hold
346
– – ﹤0.01% 1256
2022
Q4 		$8.24K Hold
346
– – ﹤0.01% 1211
2022
Q3 		$7K Hold
346
– – ﹤0.01% 1287
2022
Q2 		$7K Buy
+346
New +$6.74K ﹤0.01% 1277
2021
Q3 		– Sell
-126
Closed -$4K – 2542
2021
Q2 		$4K Buy
126
+79
+168% +$2.76K ﹤0.01% 1624
2021
Q1 		$2K Buy
+47
New +$2.11K ﹤0.01% 1874

Other funds holding RVMD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

TCI Wealth Advisors's RVMD Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Revolution Medicines (RVMD) in Q2 2023, closing a stake of 346 shares — an estimated $7.5K sold.

TCI Wealth Advisors first reported a position in RVMD in Q1 2021 and held it in 6 quarters. The position peaked at $8.24K in Q4 2022. 139 funds tracked by Wall St. Rank hold RVMD as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Revolution Medicines position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 346 Revolution Medicines shares in Q2 2023, an estimated $7.5K.
  • TCI Wealth Advisors first reported a position in Revolution Medicines in Q1 2021 and held it in 6 quarters.
  • TCI Wealth Advisors's Revolution Medicines position peaked at $8.24K in Q4 2022.
  • 139 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.